DailyIQ
Last updated 1 minute ago

VTR·Ventas, Inc.

$.
-. (-.%)
After Hours
High
$92.18
Open
$92.00
Market Cap
45.61B
52W High
$94.60
Low
$89.55
P. Close
$90.67
P/E
175.12
52W Low
$62.47
Fwd P/E
107.08
DailyIQ Est.
$99.72
Technical Score (1D)
82
BUY
News Sentiment
67
BULLISH
Scotiabank has lifted its price target for Ventas to $93 from $88, signaling a shift in its view of the company’s near‑term prospects. The upgrade reflects confidence that Ventas will deliver stronger revenue growth and margin expansion in the coming quarters. This change is likely to buoy short‑term sentiment, as traders often react to analyst target adjustments with increased buying pressure. The new target also raises the bar for the company’s earnings performance, creating a tighter window for the next 1–10 trading days. Ventas’ upcoming earnings release will be the first test of Scotiabank’s optimism, as guidance that falls short could undermine the upgrade. Investors should watch the earnings call for any updates on revenue drivers, such as property portfolio performance and operating cost controls. A stronger‑than‑expected earnings report could validate the new target and lift the stock further, while a miss could trigger a rapid correction. Analysts will also be looking for commentary on the company’s strategic initiatives, such as potential acquisitions or divestitures, that could influence future cash flows. In the next few trading days, the market will be keen to see whether Ventas can meet the heightened expectations set by Scotiabank’s revised outlook.
Earnings Summary
Ventas, Inc. is a real estate investment trust that specializes in properties supporting the aging population, including senior housing communities, outpatient medical facilities, and research centers across North America and the United Kingdom, leveraging operational expertise and data‑driven insights to deliver value to residents. In the healthcare facilities REIT sector, Ventas has consistently expanded its portfolio, generating steady revenue growth and robust earnings. Over the last six quarters, revenue increased from $1.287B in Q4 2024 to $1.657B in Q1 2026, a 28.8% rise, while EPS has consistently beaten analyst estimates, moving from $0.13 in Q4 2024 to $0.94 in Q1 2026, with all reported quarters exceeding expectations ranging from $0.05066 to $0.0848; this streak of earnings beats underscores a strong operating performance and effective cost control. Historically, Ventas has maintained a pattern of double‑digit revenue growth and EPS beats, reflecting resilience in the senior housing market and successful expansion into outpatient services, with revenue growth outpacing EPS growth but still delivering solid profitability. Recent news indicates analyst upgrades, including Scotiabank’s lift of the price target to $93 and Evercore ISI’s increase to $96, driven by confidence in revenue growth and margin expansion; the upcoming Q2 2026 earnings release is expected to provide further insight into funds from operations and capital allocation, while the appointment of a new EVP for outpatient medical & research signals strategic diversification. Investors should watch for guidance on future FFO growth, capital expenditure plans, and debt metrics, as well as any commentary on outpatient portfolio performance and potential acquisitions or divestitures that could influence the company’s valuation and cash‑flow trajectory.

EPS

EstBeatMiss
$-0.08$0.21$0.49$0.78$1.07Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.11 - -
Q1'26$0.10$0.94+840.0%
Q4'25$0.08$0.89+949.5%
Q3'25$0.05$0.12+141.9%
Q2'25$0.14$0.15+10.4%
Q1'25$0.07$0.10+35.8%

Revenue

EstBeatMiss
$1.3B$1.4B$1.5B$1.6B$1.7BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.7B - -
Q1'26$1.6B$1.7B+5.1%
Q4'25$1.5B$1.6B+2.9%
Q3'25 - $1.5B -
Q2'25 - $1.4B -
Q1'25 - $1.4B -

Market Data

VTR Stock Snapshot

VTR is currently trading at $90.66, giving Ventas, Inc. a market cap of 45.61B and a P/E ratio of 175.1. Today's range spans $89.55–$92.18, with shares opening at $92.00 and moving down $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 67/100.

Over the past year VTR has traded between $62.47 and $94.60 - the current price is +45.1% off the 52-week low and -4.2% from the high. 28 analysts cover the stock with a Buy consensus and a mean 12-month target of $97.18 (range $86.00–$110.00), implying upside of +7.2%.

Dividend-paying Real Estate stocks at the large-cap level tend to attract a different buyer mix than pure growth names - and VTR (45.61B market cap) with a BUY read (82/100) and bullish sentiment (67/100) benefits from both income-oriented and growth-oriented flows. The current P/E ratio stands at 175.1. Price: $90.66 (in the upper portion of its 52-week range in $62.47–$94.60). When technical momentum aligns with that dual-buyer base, the price path tends to be more durable than single-buyer-type momentum trades.

Earnings revision cycles in large-cap Real Estate names tend to compound: when technicals confirm a BUY thesis (82/100) and news sentiment (67/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $90.66 (in the upper portion of its 52-week range), VTR's position within the $62.47–$94.60 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.